 | United States. Congress. House. Committee on Interstate and Foreign Commerce - 1956 - 264 pages
...recognized among experts qualified by scientific training and experience to evaluate the safety of drugs as safe for use under the conditions prescribed, recommended, or suggested in the labeling thereof. Now, as a practical matter, the way this thing has worked since 1938, and we have... | |
 | United States. Congress. House. Committee on Interstate and Foreign Commerce - 1956 - 288 pages
...recognized among experts qualified by scientific training and experience to evaluate the safety of drugs as safe for use under the conditions prescribed, recommended, or suggested in the labeling thereof. Now, as a practical matter, the way this thing has worked since 1938, and we have... | |
 | United States. Congress. Senate. Committee on the Judiciary - 1961 - 1442 pages
...market the product CARISOPRODOL until the parties have mutually agreed that said product CARISOPRODOL is safe for use under the conditions prescribed, recommended or suggested in the proposed labelling for the product, and will not market the product CARISOPRODOL without the written approval... | |
 | United States. Congress. Senate. Judiciary - 1961 - 1928 pages
...market the product CARISOPRODOL until the parties have mutually ngrepd that said product CARISOPRODOL is safe for use under the conditions prescribed, recommended or suggested in the proposed labelling for the product, and will not market the product CARISOPRODOL without the written approval... | |
 | United States. Congress. House. Committee on Government Operations - 1964 - 844 pages
...not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed Inbelins thereof : or (2) The results of such tests show that such drug is unsafe for use under such... | |
 | United States. Congress. House. Interstate and Foreign Commerce - 1966 - 82 pages
...not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof ; "(B) the results of such tests show that such drug is unsafe for use under such conditions... | |
 | United States - 1966 - 556 pages
...not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions... | |
 | United States. Congress. House Interstate and Foreign Commerce - 1966 - 574 pages
...not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof; (2) the results of such tests show that such drug is unsafe for use under such conditions... | |
 | United States. Congress. House. Committee on Interstate and Foreign Commerce - 1966 - 1538 pages
...apply, he shall issue an order approving the application. "(2) In determining whether such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling thereof, the Secretary shall consider, among other relevant factors hereinbefore set forth, i A) the... | |
| |
Secretary pursuant to subsection (b), do not include adequate tests by all methods reasonably applicable to show whether or not such drug is safe for use under the conditions prescribed, recommended, or suggested in the proposed labeling... 
